Cell Genesys Shares Rise in Response to Q2 Results
Shares of Cell Genesys (Nasdaq: CEGE) are on the rise today, climbing 27 cents, nearly 9 percent, to $3.55 in Wednesday morning trading. The activity follows on the heels of the company's financial results for the second quarter ended June 30, 2007, released yesterday afternoon. Second-quarter revenue was reported at less than $0.1 million, as compared to $1 million for the same period in 2006; in the press release the company said the decrease in revenue is due to the timing of revenue from current licensing arrangements. Cell Genesys reported a net loss of $1.9 million, or 3 cents per…